1. Home
  2. HOG vs PGEN Comparison

HOG vs PGEN Comparison

Compare HOG & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$24.74

Market Cap

2.9B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.79

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOG
PGEN
Founded
1903
1998
Country
United States
United States
Employees
6400
47
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
HOG
PGEN
Price
$24.74
$7.79
Analyst Decision
Hold
Buy
Analyst Count
7
5
Target Price
★ $24.00
$8.33
AVG Volume (30 Days)
1.5M
★ 3.7M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
★ 3.05%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.97
0.03
Revenue
★ $4,473,175,000.00
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
$3.79
$81.04
P/E Ratio
★ $26.28
$258.83
Revenue Growth
N/A
★ N/A
52 Week Low
$17.09
$2.99
52 Week High
$29.22
$8.27

Technical Indicators

Market Signals
Indicator
HOG
PGEN
Relative Strength Index (RSI) 33.60 62.16
Support Level $24.09 $6.57
Resistance Level $24.68 N/A
Average True Range (ATR) 0.85 0.38
MACD -0.28 0.03
Stochastic Oscillator 2.17 72.83

Price Performance

Historical Comparison
HOG
PGEN

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: